Anika Therapeutics, Inc. (ANIK)
Surgical & Medical Instruments & Apparatus
Latest Price
$19.28
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
9.90
P/B Ratio
1.95
Valuation metrics
adjust assumptions →Base FCF: $4M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$7.01
64% downside
Institutional Ownership
85.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1.59M | $23.0M | 11.94% | -59.6K | 2026-03-31 |
| Caligan Partners LP | 1.44M | $20.0M | 10.74% | -- | 2026-03-31 |
| MORGAN STANLEY | 872.1K | $12.0M | 6.53% | +99.8K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 605.8K | $8.0M | 4.54% | -- | 2026-03-31 |
| BOOTHBAY FUND MANAGEMENT, LLC | 529.5K | $7.0M | 3.96% | -5.0K | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 502.2K | $7.0M | 3.76% | -13.5K | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 458.8K | $6.0M | 3.44% | -35.5K | 2026-03-31 |
| CAPITAL MANAGEMENT CORP /VA | 447.7K | $6.0M | 3.35% | -52.7K | 2026-03-31 |
| DEUTSCHE BANK AG\ | 353.2K | $5.0M | 2.64% | +271.9K | 2026-03-31 |
| STATE STREET CORP | 346.1K | $5.0M | 2.59% | +9.5K | 2026-03-31 |